JP2008542220A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008542220A5 JP2008542220A5 JP2008512759A JP2008512759A JP2008542220A5 JP 2008542220 A5 JP2008542220 A5 JP 2008542220A5 JP 2008512759 A JP2008512759 A JP 2008512759A JP 2008512759 A JP2008512759 A JP 2008512759A JP 2008542220 A5 JP2008542220 A5 JP 2008542220A5
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- active substance
- core
- biologically active
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 claims 10
- 238000000034 method Methods 0.000 claims 9
- 229940088623 biologically active substance Drugs 0.000 claims 6
- 239000003094 microcapsule Substances 0.000 claims 5
- 238000013270 controlled release Methods 0.000 claims 3
- 239000003960 organic solvent Substances 0.000 claims 3
- 238000005345 coagulation Methods 0.000 claims 2
- 230000015271 coagulation Effects 0.000 claims 2
- 229920001577 copolymer Polymers 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims 1
- 229920001287 Chondroitin sulfate Polymers 0.000 claims 1
- 239000004971 Cross linker Substances 0.000 claims 1
- 229920000045 Dermatan sulfate Polymers 0.000 claims 1
- 229920002307 Dextran Polymers 0.000 claims 1
- 229920002527 Glycogen Polymers 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 102000007327 Protamines Human genes 0.000 claims 1
- 108010007568 Protamines Proteins 0.000 claims 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 229940059329 chondroitin sulfate Drugs 0.000 claims 1
- 238000005354 coacervation Methods 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 230000009918 complex formation Effects 0.000 claims 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 claims 1
- 229940051593 dermatan sulfate Drugs 0.000 claims 1
- 229960002086 dextran Drugs 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 230000008014 freezing Effects 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- 229940096919 glycogen Drugs 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 229940035034 maltodextrin Drugs 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 238000010422 painting Methods 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229920000724 poly(L-arginine) polymer Polymers 0.000 claims 1
- 108010011110 polyarginine Proteins 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229920002714 polyornithine Polymers 0.000 claims 1
- 108010055896 polyornithine Proteins 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 229940048914 protamine Drugs 0.000 claims 1
- 238000010526 radical polymerization reaction Methods 0.000 claims 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05011516.1 | 2005-05-27 | ||
| EP05011516 | 2005-05-27 | ||
| EP05028165.8 | 2005-12-22 | ||
| EP05028165A EP1726299A3 (en) | 2005-05-27 | 2005-12-22 | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture |
| PCT/EP2006/004940 WO2006125620A2 (en) | 2005-05-27 | 2006-05-24 | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008542220A JP2008542220A (ja) | 2008-11-27 |
| JP2008542220A5 true JP2008542220A5 (enExample) | 2009-07-02 |
| JP5080453B2 JP5080453B2 (ja) | 2012-11-21 |
Family
ID=36935013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008512759A Expired - Fee Related JP5080453B2 (ja) | 2005-05-27 | 2006-05-24 | 非経口投与に適したコアとマイクロカプセル並びにそれらの製造方法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (2) | EP1726299A3 (enExample) |
| JP (1) | JP5080453B2 (enExample) |
| AT (1) | ATE424190T1 (enExample) |
| CA (1) | CA2609891A1 (enExample) |
| DE (1) | DE602006005491D1 (enExample) |
| DK (1) | DK1906928T3 (enExample) |
| WO (1) | WO2006125620A2 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
| GB0707612D0 (en) | 2007-04-19 | 2007-05-30 | Stratosphere Pharma Ab | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture |
| BRPI0811784A2 (pt) | 2007-05-23 | 2011-05-10 | Allergan Inc | colÁgeno reticulado e uso do mesmo |
| BRPI0811777A2 (pt) * | 2007-05-23 | 2019-09-24 | Allergan Inc | partículas de ácido hialurõnico revestidas |
| US8318695B2 (en) | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
| US8697044B2 (en) | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
| CN101896204B (zh) | 2007-11-16 | 2015-05-20 | 爱力根有限公司 | 用于治疗紫癜的组合物及方法 |
| US8394782B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
| US8394784B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
| US8357795B2 (en) | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
| AU2009288118B2 (en) | 2008-09-02 | 2014-12-11 | Allergan, Inc. | Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
| US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
| US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
| EP2544652A2 (en) | 2010-03-12 | 2013-01-16 | Allergan Industrie SAS | A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition. |
| CA2794254C (en) | 2010-03-22 | 2018-09-04 | Allergan, Inc. | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
| US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
| US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
| US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
| US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
| JP6009550B2 (ja) | 2011-06-03 | 2016-10-19 | アラーガン、インコーポレイテッドAllergan,Incorporated | 抗酸化物質を含む皮膚充填剤組成物 |
| US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
| US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
| WO2016051219A1 (en) | 2014-09-30 | 2016-04-07 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
| WO2016128783A1 (en) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions and methods for improving skin appearance |
| ES2774051T3 (es) | 2015-02-13 | 2020-07-16 | Allergan Ind Sas | Implantes para esculpir, aumentar o corregir características faciales, tales como la barbilla |
| WO2025137151A2 (en) | 2023-12-18 | 2025-06-26 | The Johns Hopkins University | Dendrimer compositions for the treatment of atherosclerosis, obesity, and metabolic syndromes |
| CN118146569B (zh) * | 2024-01-24 | 2024-11-22 | 中国海洋大学 | 透明质酸-青蒿琥酯-聚精氨酸纳米粒、制备方法及应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60100516A (ja) * | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
| WO1992016191A1 (en) * | 1991-03-25 | 1992-10-01 | Fujisawa Pharmaceutical Co., Ltd. | Long-acting pharmaceutical preparation |
| DE4201179A1 (de) * | 1992-01-17 | 1993-07-22 | Alfatec Pharma Gmbh | Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung |
| KR100201352B1 (ko) * | 1995-03-16 | 1999-06-15 | 성재갑 | 단일주사 백신 제형 |
| SE505146C2 (sv) | 1995-10-19 | 1997-06-30 | Biogram Ab | Partiklar för fördröjd frisättning |
| EP0994700A4 (en) * | 1997-07-18 | 2000-10-18 | Bayer Ag | METHODS FOR REMOVING SOLVENT RESIDUES FROM COMPOSITIONS FOR THE NASAL ADMINISTRATION OF ACTIVE SUBSTANCES |
| SE9903236D0 (sv) | 1999-09-10 | 1999-09-10 | Astra Ab | Method to obtain microparticles |
| DE60040012D1 (de) * | 1999-11-12 | 2008-10-02 | Fibrogen Inc | Rekombinantes gelatin in impstoffen |
| JP2004510730A (ja) * | 2000-10-06 | 2004-04-08 | ヤゴテック アーゲー | 非経口的投与可能な制御放出微粒子調製物 |
| ATE397020T1 (de) | 2000-10-06 | 2008-06-15 | Pacira Pharmaceuticals Inc | Pharmazeutisch verwendbare stärke und deren herstellungsverfahren |
| JP2004510724A (ja) | 2000-10-06 | 2004-04-08 | ヤゴテック アーゲー | 分子量の低下した澱粉からなる微粒子中に埋め込まれた免疫学的活性物質を含むワクチン組成物 |
-
2005
- 2005-12-22 EP EP05028165A patent/EP1726299A3/en not_active Withdrawn
-
2006
- 2006-05-24 DK DK06743048T patent/DK1906928T3/da active
- 2006-05-24 JP JP2008512759A patent/JP5080453B2/ja not_active Expired - Fee Related
- 2006-05-24 CA CA002609891A patent/CA2609891A1/en not_active Abandoned
- 2006-05-24 EP EP06743048A patent/EP1906928B1/en not_active Not-in-force
- 2006-05-24 WO PCT/EP2006/004940 patent/WO2006125620A2/en not_active Ceased
- 2006-05-24 AT AT06743048T patent/ATE424190T1/de not_active IP Right Cessation
- 2006-05-24 DE DE602006005491T patent/DE602006005491D1/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008542220A5 (enExample) | ||
| Li et al. | pH-responsive lignin-based complex micelles: Preparation, characterization and application in oral drug delivery | |
| Rao et al. | Synthesis and Characterization of biodegradable Poly (Vinyl caprolactam) grafted on to sodium alginate and its microgels for controlled release studies of an anticancer drug | |
| Tu et al. | Alginate microparticles prepared by spray–coagulation method: Preparation, drug loading and release characterization | |
| US9220689B2 (en) | Nanoparticles | |
| CN105494430B (zh) | 一种载银低分子量壳聚糖复合微球抗菌剂及其制备方法 | |
| Liu et al. | Fabrication of degradable polymer microspheres via pH-responsive chitosan-based Pickering emulsion photopolymerization | |
| Wei et al. | Halloysite nanotubes as particulate emulsifier: Preparation of biocompatible drug‐carrying PLGA microspheres based on pickering emulsion | |
| Li et al. | Functionalization of halloysite nanotubes by enlargement and hydrophobicity for sustained release of analgesic | |
| CN109293976B (zh) | 一种多孔壳聚糖微球的制备方法 | |
| CN100532438C (zh) | 一种淀粉微球及其制备方法 | |
| de Matos Fonseca et al. | Chitosan microparticles embedded with multi-responsive poly (N-vinylcaprolactam-co-itaconic acid-co-ethylene-glycol dimethacrylate)-based hydrogel nanoparticles as a new carrier for delivery of hydrophobic drugs | |
| JP2005511335A5 (enExample) | ||
| CN101225179A (zh) | 一种大面积有序多孔膜材料及其制备方法 | |
| JP4471655B2 (ja) | 水系分散ヒドロキシプロピルメチルセルロースフタレートナノ粒子の製造方法 | |
| CN106832129A (zh) | 一种衣康酸均聚物接枝羧甲基壳聚糖纳米粒的制备方法 | |
| CN102658072A (zh) | 单分散壳聚糖中空微球的制备方法 | |
| He et al. | Cagelike polymer microspheres with hollow core/porous shell structures | |
| CN104127386B (zh) | 一种大叶茜草素/壳聚糖纳米微球及其制备方法和应用 | |
| CN101564668B (zh) | 微胶囊的制备方法 | |
| Tan et al. | Preparation, characterization, and drug‐release properties of PEG‐DA‐based copolymer hydrogel microspheres | |
| CN102631951B (zh) | 一种制备具有高效催化性能的有机无机杂化纳米二氧化钛空心球的方法 | |
| CN105131157A (zh) | 一种云母钛原位填充的聚苯乙烯银灰色保温材料的制备方法、其产品及应用 | |
| CN103894122B (zh) | 可溶型药物负载微胶囊的制备方法 | |
| Hata et al. | Preparation of hollow poly (divinyl benzene) particles with multiple holes in the shell by microsuspension polymerization with the SaPSeP method |